Skip to main content
. 2023 Nov-Dec;86(6):e2021-0462. doi: 10.5935/0004-2749.2021-0462

Table 3.

Comparison of eyes with a final CRT value below and above 250 µm

Final CRT
250 µm (n=15)
Final CRT >250 µm (n=21) p-value
Age 57.9,9 ± 8.9 64.6 ± 8.8 0.087
Gender
Male (%) 53.3 52.4 0.455
Female (%) 46.7 47.6
Time of DM (years) 10.2 ± 3.6 12.5 ± 1.7 0.101
HbA1c (%) 7.23 ± 0.44 7.43 ± 0.36 0.240
Baseline BCVA (logMAR) 0,60 ± 0.28 0.52 ± 0.29 0.519
Baseline CST (µm) 504.2 ± 190.1 489.1 ± 131.3 0.820
Baseline total cyst area (µm2) 10036.0 ± 3998.9 11003 ± 3736 0.556
Baseline mean intracystic reflectance 41.2 ± 6.3 44.5 ± 8.1 0.308
Hyperreflective dots 15.9 ± 9.2 14.5 ± 8.8 0.711
Presence of DRIL
Yes (%) 40.0 42.8 0.322
No (%) 60.0 57.2
Presence of subretinal fluid
Yes (%) 33.3 47.6 0.386
No (%) 66.7 52.4
Presence of cysts in outer retinal layer
Yes (%) 77.8 53.3 0.225
No (%) 22.2 46.7
Presence of disrupted EZ
Yes (%) 33.3 42.8 0.208
No (%) 66.7 57.2
Presence of TPHM
Yes (%) 33.3 42.8 0.424
No (%) 66.7 57.2
Final CRT (µm) 219.3 ± 24.2 339.4 ± 67.8 0.021*
Final total cyst area (µm2) 511.2 ± 134.3 1672.5 ± 239.5 0.004*

BCVA= best-corrected visual acuity; CST= central subfield thickness; CRT= central retinal thickness; DM= diabetes mellitus; DRIL= disorganization of retinal inner layers; HbA1c= hemoglobin A1C; TPHM= taut posterior hyaloid membrane.